MURA: muraloncology.com Kompaniya qiymatining sof foydaga nisbati

Mural Oncology - MURA emitenti grafik logotipi

Mural Oncology plc (MURA) o'smalarga qarshi kurashish uchun eng zamonaviy immunoterapiya agentlarini ishlab chiqishda yuqori obro'ga ega bo'lib, uning faoliyati iqtisodiy sikllardan mustaqil qolgan va buning o'rniga klinik sinovlar natijalariga tayanadi. Ushbu narxlar grafigi -0.30 qiymatini aks ettiradi. Biznes barqarorligi Alkermes kompaniyasidan o'tgan va uzoq muddatli opsionlar bilan rag'batlantirilgan yetakchi olimlardan iborat maxsus xodimlar tomonidan ta'minlanadi.

Narx-foyda koeffitsiyenti: Mural Bio (MURA) 15.08.2024 - 20.12.2025 uchun

Mural Oncology PLC (MURA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:MURA Mural Bio
Mural Oncology yetakchi tovari

Emitentning uzoq muddatli ishonchliligi biznesning foyda keltirish qobiliyati bilan belgilanadi, P/E bozor baholashi esa aktivning haddan tashqari sotib olingani yoki qadrsizlanganini aniqlash uchun ushbu ko'rsatkichni joriy aksiya narxi bilan solishtiradi. Mural Oncology plc (MURA) uchun ushbu ko'rsatkich spekulyativ bo'lib qolmoqda, chunki tijorat mahsulotlarining va takrorlanuvchi daromadning yo'qligi koeffitsient hisob-kitoblarini mutlaqo klinik dori sinovlari natijalariga bog'liq qiladi.

Raqobatdosh kompaniyalar

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology, Inc. - Bozor narxining sof foydaga nisbati|HURA (TuHURA Biosciences) - Narx-foyda koeffitsiyenti|TARA: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti FATE|WHWK: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TCRX (TScan Therapeutics Inc)|Biznesning o‘zini qoplash muddati Champions Oncology Inc|P/E multiplikatori XBIT (XBiotech Inc.)|Kompaniya qiymatining sof foydaga nisbati CVM|OS Therapies Inc. - P/E multiplikatori|RADX - P/E multiplikatori|ARTV: P/E multiplikatori|ANL: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti VERU|TPST: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati xiliotx.com (XLO)|Renovaro - Narx-foyda multiplikatori|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV